ClinicalTrials.Veeva

Menu

One-stage Bone Lengthening in the Management of Brachymetatarsia (BRACHYONESTAGE)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Brachymetatarsia

Study type

Observational

Funder types

Other

Identifiers

NCT04287127
RECHMPL20_0037

Details and patient eligibility

About

Brachymetatarsia is a shortening in length of a metatarsal exceeding 5mm. This congenital anomaly most often affecting women and the second metatarsal is associated with frequent aesthetic disorders leading patients to consult. The one-time lengthening technique is described for the management of brachymetatarsia with good functional results. However, the metatarsal elongation in one time is limited to 15 millimeters, to avoid complications.

No study has presented the consequences of hypocorrection, especially cosmetic. Our hypothesis is that undercorrection (Hypocorrection) is associated with a higher rate of cosmetic dissatisfaction.

Enrollment

25 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients operated on for a one-time lengthening for isolated brachymetatarsia
  • Major patients

Exclusion criteria

  • Patient refusing to participate in research

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems